nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinic and community-based approach to hypertension control for underserved minority population: Design and methods
|
Johnson, Richard A. |
|
2004 |
|
3 |
p. 76- 1 p. |
artikel |
2 |
Acute and prophylactic management of migraine
|
Dodick, David W. |
|
2001 |
|
3 |
p. 36-52 17 p. |
artikel |
3 |
Antecedents to effective treatment of hypertension in Hispanic populations
|
Soto-Greene, Maria L. |
|
2004 |
|
3 |
p. 30-38 9 p. |
artikel |
4 |
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopaus
|
Archer, D.F. |
|
1999 |
|
3 |
p. 53- 1 p. |
artikel |
5 |
Assessing psychiatric illness in geriatric patients
|
Tune, Larry |
|
2001 |
|
3 |
p. 23-33 11 p. |
artikel |
6 |
A streamlined method for diagnosing common psychiatric disorders in primary care
|
Staab, Jeffrey P. |
|
2001 |
|
3 |
p. 1-7 7 p. |
artikel |
7 |
Awareness of hypertension and diabetes in the Hispanic community
|
Aranda Jr, Juan M. |
|
2004 |
|
3 |
p. 7-15 9 p. |
artikel |
8 |
A 12-year-old student athlete with exercise-induced bronchospasm: Getting Jenny B. Back on track
|
Mosnaim, Giselle |
|
2009 |
|
3 |
p. 30-39 10 p. |
artikel |
9 |
Barriers to health promotion and disease prevention in the Latino population
|
Betancourt, Joseph R. |
|
2004 |
|
3 |
p. 16-29 14 p. |
artikel |
10 |
Cardiometabolic risk and risk management
|
|
|
2007 |
|
3 |
p. 3-5 3 p. |
artikel |
11 |
Cardiovascular disease and modifiable cardiometabolic risk factors
|
Cannon, Christopher P. |
|
2007 |
|
3 |
p. 11-28 18 p. |
artikel |
12 |
Chronic insomnia — A challenge for the future
|
Miller, Ellen H. |
|
2003 |
|
3 |
p. 3-4 2 p. |
artikel |
13 |
Clinical implications of the insulin resistance syndrome
|
Garvey, W.Timothy |
|
1998 |
|
3 |
p. 13-28 16 p. |
artikel |
14 |
Clinical importance of identifying immunoglobulin E-mediated disease in patients with Asthma
|
Casale, Thomas B. |
|
2009 |
|
3 |
p. 20-29 10 p. |
artikel |
15 |
Clinical manifestations of migraine
|
Kunkel, Robert S. |
|
2001 |
|
3 |
p. 18-25 8 p. |
artikel |
16 |
CME information migraine
|
|
|
2001 |
|
3 |
p. iii- 1 p. |
artikel |
17 |
CME information obesity
|
|
|
1999 |
|
3 |
p. 54-58 5 p. |
artikel |
18 |
CME information office psychiatry
|
|
|
2001 |
|
3 |
p. 61-66 6 p. |
artikel |
19 |
CME information to diabetes
|
|
|
1998 |
|
3 |
p. 72-74 3 p. |
artikel |
20 |
CME test answers
|
|
|
2004 |
|
3 |
p. 85-87 3 p. |
artikel |
21 |
CME test answers cardiometabolic risk and risk management
|
|
|
2007 |
|
3 |
p. 89-91 3 p. |
artikel |
22 |
CME test answer sheet and evaluation form for cardiometabolic risk and risk management
|
|
|
2007 |
|
3 |
p. 87-88 2 p. |
artikel |
23 |
CME test answer sheet and evaluat ion form for chronic insomnia
|
|
|
2003 |
|
3 |
p. 67-72 6 p. |
artikel |
24 |
CME test answer sheet and evaluation form for hypertension in hispanics
|
|
|
2004 |
|
3 |
p. 83-84 2 p. |
artikel |
25 |
CME test answer sheet and evaluation form for migraine
|
|
|
2001 |
|
3 |
p. 69-74 6 p. |
artikel |
26 |
CME test questions
|
|
|
2004 |
|
3 |
p. 79-81 3 p. |
artikel |
27 |
CME test questions cardiometabolic risk and risk management
|
|
|
2007 |
|
3 |
p. 83-85 3 p. |
artikel |
28 |
CME test questions chronic insomnia
|
|
|
2003 |
|
3 |
p. 63-65 3 p. |
artikel |
29 |
CME test questions migraine
|
|
|
2001 |
|
3 |
p. 66-68 3 p. |
artikel |
30 |
Cognitive behavior therapy for chronic insomnia
|
Smith, Michael T. |
|
2003 |
|
3 |
p. 28-40 13 p. |
artikel |
31 |
Comparative aspects of triptans in treating migraine
|
Adelman, James U. |
|
2001 |
|
3 |
p. 53-64 12 p. |
artikel |
32 |
Comprehensive management of cardiometabolic risk factors
|
Early, James |
|
2007 |
|
3 |
p. 69-80 12 p. |
artikel |
33 |
Continuing education answer sheet and evaluation form for Diabetes
|
|
|
1998 |
|
3 |
p. 75-76 2 p. |
artikel |
34 |
Continuing education answer sheet and evaluation form for obesity
|
|
|
1999 |
|
3 |
p. 59-60 2 p. |
artikel |
35 |
Dyslipidemia and glucose dysregulation in overweight and obese patients
|
LeRoith, Derek |
|
2007 |
|
3 |
p. 38-52 15 p. |
artikel |
36 |
Education: Nationally achievable solutions
|
Pepine, Carl J. |
|
2004 |
|
3 |
p. 65-70 6 p. |
artikel |
37 |
Etiology and pathogenesis of obesity
|
Bray, George A. |
|
1999 |
|
3 |
p. 1-15 15 p. |
artikel |
38 |
Factors influencing unawareness of hypertension among older Mexican Americans
|
Johnson, Richard A. |
|
2004 |
|
3 |
p. 77- 1 p. |
artikel |
39 |
From the page to the clinic: Implementing new National Asthma Education and Prevention Program guidelines
|
Rachelefsky, Gary S. |
|
2009 |
|
3 |
p. 9-19 11 p. |
artikel |
40 |
Generalized anxiety disorder
|
Gorman, Jack M. |
|
2001 |
|
3 |
p. 37-43 7 p. |
artikel |
41 |
Glucose control in type 1 diabetes: From conventional to intensive therapy
|
Zinman, Bernard |
|
1998 |
|
3 |
p. 29-38 10 p. |
artikel |
42 |
Hormone replacement therapy and sleep-disordered breathing
|
|
|
2003 |
|
3 |
p. 61- 1 p. |
artikel |
43 |
Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition
|
Peters, Stephen |
|
2009 |
|
3 |
p. 50-53 4 p. |
artikel |
44 |
Hydrofluoroalkane tear-out sheet
|
|
|
2009 |
|
3 |
p. 61- 1 p. |
artikel |
45 |
Hypertension in ethnic populations: Tailoring treatments
|
Kountz, David S. |
|
2004 |
|
3 |
p. 39-48 10 p. |
artikel |
46 |
Inhaled anticholinergics and the long-term treatment of chronic obstructive pulmonary disease: Weighing benefits and risks
|
Hogarth, D. Kyle |
|
2009 |
|
3 |
p. 45-49 5 p. |
artikel |
47 |
Insomnia: Epidemiology, characteristics, and consequences
|
Roth, Thomas |
|
2003 |
|
3 |
p. 5-15 11 p. |
artikel |
48 |
Insomnia in the geriatric patient
|
Avidan, Alon Y. |
|
2003 |
|
3 |
p. 51-60 10 p. |
artikel |
49 |
Insomnia in women
|
Krystal, Andrew D. |
|
2003 |
|
3 |
p. 41-50 10 p. |
artikel |
50 |
Intervention study supports homocysteine-lowering treatment to slow progression of atherosclerosis
|
Johnson, Richard A. |
|
2001 |
|
3 |
p. 58-60 3 p. |
artikel |
51 |
Intranasal lidocaine for the treatment of migraine headache: A randomised, controlled trial
|
Blanda, M. |
|
2001 |
|
3 |
p. 65- 1 p. |
artikel |
52 |
Introdcution
|
Garvey, W.Timothy |
|
1998 |
|
3 |
p. iv- 1 p. |
artikel |
53 |
Introduction
|
Rachelefsky, Gary S. |
|
2009 |
|
3 |
p. 6-8 3 p. |
artikel |
54 |
Introduction
|
Neubauer, David N. |
|
2003 |
|
3 |
p. 1- 1 p. |
artikel |
55 |
Introduction
|
Nesto, Richard W. |
|
2007 |
|
3 |
p. 9-10 2 p. |
artikel |
56 |
Introduction
|
Heber, David |
|
1999 |
|
3 |
p. iv- 1 p. |
artikel |
57 |
Introduction
|
Quan, Martin |
|
2001 |
|
3 |
p. iv-v nvt p. |
artikel |
58 |
Introduction
|
Mathew, Ninan T. |
|
2001 |
|
3 |
p. vi- 1 p. |
artikel |
59 |
Introduction
|
Aranda Jr., Juan M. |
|
2004 |
|
3 |
p. 5-6 2 p. |
artikel |
60 |
Issues in achieving compliance with antihypertensive treatment in the Latino population
|
Perez-Stable, Eliseo J. |
|
2004 |
|
3 |
p. 49-64 16 p. |
artikel |
61 |
Management of glycemia in type 2 diabetes
|
Buse, John B. |
|
1998 |
|
3 |
p. 39-57 19 p. |
artikel |
62 |
Managing the suicidal patient
|
Nicholas, Linda M. |
|
2001 |
|
3 |
p. 47-54 8 p. |
artikel |
63 |
New classification and diagnostic criteria for diabetes mellitus
|
Gavin, James R. |
|
1998 |
|
3 |
p. 1-12 12 p. |
artikel |
64 |
Obesity and its comorbid conditions
|
Khaodhiar, Lalita |
|
1999 |
|
3 |
p. 17-31 15 p. |
artikel |
65 |
Overview
|
Nemeroff, Charles B. |
|
2001 |
|
3 |
p. vi- 1 p. |
artikel |
66 |
Overweight and obesity: Key components of cardiometabolic risk
|
Aronne, Louis J. |
|
2007 |
|
3 |
p. 29-37 9 p. |
artikel |
67 |
Pathophysiology, epidemiology, and impact of migraine
|
Mathew, Ninan T. |
|
2001 |
|
3 |
p. 1-17 17 p. |
artikel |
68 |
Pharmacologic approaches for the treatment of chronic insomnia
|
Neubauer, David N. |
|
2003 |
|
3 |
p. 16-27 12 p. |
artikel |
69 |
Pharmacotherapy in the treatment of obesity
|
Heber, David |
|
1999 |
|
3 |
p. 33-42 10 p. |
artikel |
70 |
Pitfalls in migraine diagnosis and management
|
Smith, Timothy R. |
|
2001 |
|
3 |
p. 26-35 10 p. |
artikel |
71 |
Prevention of diabetes complications
|
Colwell, John A. |
|
1998 |
|
3 |
p. 58-71 14 p. |
artikel |
72 |
Publisher's note
|
|
|
2003 |
|
3 |
p. ii- 1 p. |
artikel |
73 |
Recreational effect against gallbladde disease linked to physical activity
|
Leitzman, M.F. |
|
1999 |
|
3 |
p. 52- 1 p. |
artikel |
74 |
Role of stress, arousal, and coping skills in primary insomnia
|
|
|
2003 |
|
3 |
p. 62- 1 p. |
artikel |
75 |
Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors
|
Johnson, Richard A. |
|
2007 |
|
3 |
p. 81- 1 p. |
artikel |
76 |
Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts
|
Quan, Martin |
|
2009 |
|
3 |
p. 54-60 7 p. |
artikel |
77 |
The blockade of the endocannabinoid CB1 receptors and its influence on cardiometabolic risk: Lesson from rimonabant in obesity (RIO) trials
|
Johnson, Richard A. |
|
2007 |
|
3 |
p. 82- 1 p. |
artikel |
78 |
The central role of lifestyle change in long-term weight management
|
Brownell, Kelly D. |
|
1999 |
|
3 |
p. 43-51 9 p. |
artikel |
79 |
The evaluation and treatment of depression in primary care
|
Compton, Michael T. |
|
2001 |
|
3 |
p. 10-20 11 p. |
artikel |
80 |
Treatment of hypertension in the hispanic community: Cultural case studies
|
Aranda Jr, Juan M. |
|
2004 |
|
3 |
p. 71-75 5 p. |
artikel |
81 |
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors
|
Gerich, John E. |
|
2007 |
|
3 |
p. 53-68 16 p. |
artikel |
82 |
Using long-acting β2-agonists safely: What will be the impact of the US Food and Drug Administration's panel recommendations?
|
Smart, Brian A. |
|
2009 |
|
3 |
p. 40-44 5 p. |
artikel |